Your business’ success is defined by its ability to be unique. Whether it’s a secret sauce, a few lines of code, the mechanics of a machine, or the way you get things done, your commercial viability is the result of the value that is delivered by your unique.
is a boutique intellectual property and commercial law practice. We are dedicated to helping clients protect, grow and enforce their intellectual property assets through expert and dependable advice.
When it comes to protecting your unique, you are only as strong as your weakest link. Our clients enjoy unparalleled attention to detail from our IP, Corporate & Commercial Legal services.
As a team of specialists, we are incredibly focused on helping our clients achieve their commercial goals. We believe the best way to do this is through relationships built on invested interest and mutually-determined value. We immerse ourselves in your business and brand to achieve the best possible outcome for your circumstances.
“Buchanan has been a great addition to the Made Establishment group and a vital partner in recent times. They have the ability to be adaptable and nimble depending on circumstances and have, and continue to offer critical advice and legal direction on major governance and risk issues, but at all times remaining commercial in their advisory capacity.”
- Employment Law
- Industrial Relations
- Intellectual Property
- Trade Marks
- Commercial Negotiations
- Contract Drafting
- IT Procurement
- Competition Terms
Managing Intellectual Property Assets and meeting your director’s duties Placing IP front and centre on the Board’s agenda maximises the potential for favourable commercial outcomes and helps to ensure company directors comply with their director duties. As a simple proposition, practising Good IP Governance* in relation to a company’s intellectual property assets (IP Assets) will
A recent decision of the Federal Court of Australia reiterates the need for businesses to ensure any comparative advertising claims are capable of substantiation through current and relevant scientific evidence or otherwise risk breaching the Australian Consumer Law. The case of GlaxoSmithKline Australia Pty Ltd v Reckitt Benckiser (Australia) Pty Limited (No 2)  FCA